{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:31:04Z","timestamp":1789061464200,"version":"build-2803163510"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Given the lack of specificity of current blood and urine testing and the resistance\/inability to perform pancreas allograft biopsies, additional noninvasive investigational tools to assess the risk for rejection are needed. This study examines the clinical impact of molecular HLA matching in a large single-center simultaneous pancreas-kidney (SPK) transplant program.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>The study cohort comprised 238 SPK recipients between 2012 and 2021. The number of HLA mismatches, eplet, Snow (that counts the number of protein-specific surface-accessible donor HLA amino acid mismatches), and predicted indirectly recognizable T-cell epitope (PIRCHE, version 4.2; 100%) loads were calculated on the basis of 2-field HLA-A, -B, -C, -DRB1, and -DQB1 typing of recipients and donors. Univariable and multivariable Cox proportional hazard, as well as Kaplan-Meier analyses, were performed considering either first rejection events of a graft or a composite endpoint of de novo donor-specific antibodies, first rejection, and uncensored graft failure of either organ.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Kaplan-Meier analyses considered class II PIRCHE groups separated by a threshold of 7. From the considered histocompatibility metrics, multivariable regression analysis revealed only PIRCHE-II derived from donor HLA class II as statistically significantly correlated with clinical events and rejection after SPK, mostly driven by pancreas rejections. Furthermore, longer dialysis time and the induction agent had significant negative impacts on the defined composite endpoint.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Our data support the clinical benefit of incorporating PIRCHE scores for the interpretation of class II HLA mismatches among patients undergoing SPK transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/txd.0000000000001764","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:00:49Z","timestamp":1738958449000},"page":"e1764","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Predicted Indirectly Recognizable T-cell Epitope (PIRCHE) Load Correlates With Rejection Events After Simultaneous Pancreas-Kidney Transplantation"],"prefix":"10.1097","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1667-7465","authenticated-orcid":false,"given":"Sandesh","family":"Parajuli","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Niemann","sequence":"additional","affiliation":[{"name":"PIRCHE AG, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany L.","family":"Dale","sequence":"additional","affiliation":[{"name":"PIRCHE AG, Berlin, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Hidalgo","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"UWHealth Transplant Center, Madison, WI."},{"name":"HLA Laboratory, University of Wisconsin School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Nephrology, School of Medicine, Virginia Commonwealth University, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dixon","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"UWHealth Transplant Center, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Odorico","sequence":"additional","affiliation":[{"name":"Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI."},{"name":"UWHealth Transplant Center, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Mandelbrot","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"R1-20250207","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/MOT.0000000000000146","article-title":"Simultaneous pancreas and kidney transplantation: current trends and future directions.","volume":"20","author":"Redfield","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R2-20250207","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5500\/wjt.v4.i2.102","article-title":"Transplant options for patients with type 2 diabetes and chronic kidney disease.","volume":"4","author":"Fourtounas","year":"2014","journal-title":"World J Transplant"},{"key":"R3-20250207","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/SLA.0b013e3181b76d2b","article-title":"One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up.","volume":"250","author":"Sollinger","year":"2009","journal-title":"Ann Surg"},{"key":"R4-20250207","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ndt\/gfs613","article-title":"Mortality in diabetes: pancreas transplantation is associated with significant survival benefit.","volume":"28","author":"van Dellen","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"R5-20250207","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/ajt.12020","article-title":"OPTN\/SRTR 2011 annual data report: pancreas.","volume":"13","author":"Kandaswamy","year":"2013","journal-title":"Am J Transplant"},{"issue":"Suppl 2","key":"R6-20250207","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/ajt.16979","article-title":"OPTN\/SRTR 2020 annual data report: pancreas.","volume":"22","author":"Kandaswamy","year":"2022","journal-title":"Am J Transplant"},{"key":"R7-20250207","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.12443","article-title":"Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.","volume":"13","author":"Niederhaus","year":"2013","journal-title":"Am J Transplant"},{"key":"R8-20250207","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/ajt.13734","article-title":"HLA-A, -B, -C, -DR, and -DQ matching in pancreas transplantation: effect on graft rejection and survival.","volume":"16","author":"Rudolph","year":"2016","journal-title":"Am J Transplant"},{"key":"R9-20250207","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/ajt.12167","article-title":"Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation.","volume":"13","author":"Dong","year":"2013","journal-title":"Am J Transplant"},{"key":"R10-20250207","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40472-015-0061-x","article-title":"Diagnosis and treatment of pancreas rejection.","volume":"2","author":"Redfield","year":"2015","journal-title":"Curr Transplant Rep"},{"key":"R11-20250207","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/tri.13007","article-title":"Concurrent biopsies of both grafts in recipients of simultaneous pancreas and kidney demonstrate high rates of discordance for rejection as well as discordance in type of rejection\u2014a retrospective study.","volume":"31","author":"Parajuli","year":"2018","journal-title":"Transpl Int"},{"key":"R12-20250207","article-title":"Indications, techniques, and barriers for pancreas transplant biopsy: a consensus perspective from a survey of US centers.","author":"Singh","journal-title":"Transplantation"},{"key":"R13-20250207","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1097\/TP.0000000000004489","article-title":"Higher fasting pretransplant c-peptide levels in type 2 diabetics undergoing simultaneous pancreas-kidney transplantation are associated with posttransplant pancreatic graft dysfunction.","volume":"107","author":"Parajuli","year":"2023","journal-title":"Transplantation"},{"key":"R14-20250207","first-page":"435","article-title":"Outcomes of pancreas transplant recipients with de novo donor-specific antibodies.","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"R15-20250207","doi-asserted-by":"crossref","first-page":"e1402","DOI":"10.1097\/TXD.0000000000001402","article-title":"Induction in pancreas transplantation: T-cell depletion versus IL-2 receptor blockade.","volume":"8","author":"Aziz","year":"2022","journal-title":"Transplant Direct"},{"key":"R16-20250207","doi-asserted-by":"crossref","first-page":"e1287","DOI":"10.1097\/TXD.0000000000001287","article-title":"Utility of protocol pancreas biopsies for de novo donor-specific antibodies.","volume":"8","author":"Parajuli","year":"2022","journal-title":"Transplant Direct"},{"key":"R17-20250207","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1600-6143.2008.02212.x","article-title":"Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel.","volume":"8","author":"Drachenberg","year":"2008","journal-title":"Am J Transplant"},{"key":"R18-20250207","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1111\/ajt.14393","article-title":"Donor-recipient matching based on predicted indirectly recognizable HLA epitopes independently predicts the incidence of de novo donor-specific HLA antibodies following renal transplantation.","volume":"17","author":"Lachmann","year":"2017","journal-title":"Am J Transplant"},{"key":"R19-20250207","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1111\/ajt.15177","article-title":"HLA-DR\/DQ molecular mismatch: a prognostic biomarker for primary alloimmunity.","volume":"19","author":"Wiebe","year":"2019","journal-title":"Am J Transplant"},{"key":"R20-20250207","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2020010019","article-title":"Eplet Mismatch load and de novo occurrence of donor-specific anti-HLA antibodies, rejection, and graft failure after kidney transplantation: an observational cohort study.","volume":"31","author":"Senev","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R21-20250207","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1053\/j.ajkd.2022.04.009","article-title":"Association of predicted HLA T-cell epitope targets and T-cell-mediated rejection after kidney transplantation.","volume":"80","author":"Senev","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"R22-20250207","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/TP.0000000000002117","article-title":"A comparison of HLA molecular mismatch methods to determine HLA immunogenicity.","volume":"102","author":"Wiebe","year":"2018","journal-title":"Transplantation"},{"key":"R23-20250207","doi-asserted-by":"crossref","first-page":"1110292","DOI":"10.3389\/fimmu.2023.1110292","article-title":"Immunologic risk stratification of pediatric heart transplant patients by combining HLA-EMMA and PIRCHE-II.","volume":"14","author":"Ellison","year":"2023","journal-title":"Front Immunol"},{"key":"R24-20250207","doi-asserted-by":"crossref","first-page":"1005601","DOI":"10.3389\/fimmu.2022.1005601","article-title":"Snowflake epitope matching correlates with child-specific antibodies during pregnancy and donor-specific antibodies after kidney transplantation.","volume":"13","author":"Niemann","year":"2022","journal-title":"Front Immunol"},{"key":"R25-20250207","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/tri.12887","article-title":"De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.","volume":"30","author":"Kauke","year":"2017","journal-title":"Transpl Int"},{"key":"R26-20250207","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2018.00321","article-title":"PIRCHE-II is related to graft failure after kidney transplantation.","volume":"9","author":"Geneugelijk","year":"2018","journal-title":"Front Immunol"},{"key":"R27-20250207","doi-asserted-by":"crossref","first-page":"949933","DOI":"10.3389\/fimmu.2022.949933","article-title":"PIRCHE-II scores prove useful as a predictive biomarker among kidney transplant recipients with rejection: an analysis of indication and follow-up biopsies.","volume":"13","author":"Spitznagel","year":"2022","journal-title":"Front Immunol"},{"key":"R28-20250207","first-page":"30","article-title":"Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?","volume":"30","author":"Niemann","year":"9900","journal-title":"Curr Opin Organ Transplant"},{"key":"R29-20250207","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/tan.12322","article-title":"Update of the HLA class I eplet database in the website based registry of antibody-defined HLA epitopes.","volume":"83","author":"Duquesnoy","year":"2014","journal-title":"Tissue Antigens"},{"key":"R30-20250207","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/iji.12359","article-title":"Matching donor and recipient based on predicted indirectly recognizable human leucocyte antigen epitopes.","volume":"45","author":"Geneugelijk","year":"2018","journal-title":"Int J Immunogenet"},{"key":"R31-20250207","doi-asserted-by":"crossref","first-page":"e15260","DOI":"10.1111\/tan.15260","article-title":"Repeated local ellipsoid protrusion supplements HLA surface characterization.","volume":"103","author":"Niemann","year":"2024","journal-title":"HLA"},{"key":"R32-20250207","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00251-019-01140-x","article-title":"PIRCHE-II: an algorithm to predict indirectly recognizable HLA epitopes in solid organ transplantation.","volume":"72","author":"Geneugelijk","year":"2020","journal-title":"Immunogenetics"},{"key":"R33-20250207","doi-asserted-by":"crossref","first-page":"159479","DOI":"10.1155\/2014\/159479","article-title":"Predicting alloreactivity in transplantation.","volume":"2014","author":"Geneugelijk","year":"2014","journal-title":"J Immunol Res"},{"key":"R34-20250207","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1111\/ajt.13508","article-title":"Predicted indirectly recognizable HLA epitopes presented by HLA-DRB1 are related to HLA antibody formation during pregnancy.","volume":"15","author":"Geneugelijk","year":"2015","journal-title":"Am J Transplant"},{"key":"R35-20250207","doi-asserted-by":"crossref","first-page":"1067075","DOI":"10.3389\/fimmu.2022.1067075","article-title":"Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: a retrospective cohort study.","volume":"13","author":"Lemieux","year":"2022","journal-title":"Front Immunol"},{"key":"R36-20250207","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trim.2018.06.006","article-title":"The clinical significance of epitope mismatch load in kidney transplantation: a multicentre study.","volume":"50","author":"Dani\u00ebls","year":"2018","journal-title":"Transpl Immunol"},{"key":"R37-20250207","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/lt.25357","article-title":"Class II human leukocyte antigen epitope mismatch predicts de novo donor-specific antibody formation after liver transplantation.","volume":"25","author":"Meszaros","year":"2019","journal-title":"Liver Transpl"},{"key":"R38-20250207","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/lt.25323","article-title":"Donor-specific antibodies in pediatric intestinal and multivisceral transplantation: the role of liver and human leukocyte antigen mismatching.","volume":"24","author":"Talayero","year":"2018","journal-title":"Liver Transpl"},{"key":"R39-20250207","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3727\/096368916X691673","article-title":"Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation.","volume":"25","author":"Chaigne","year":"2016","journal-title":"Cell Transplant"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001764","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T20:01:02Z","timestamp":1738958462000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001764","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}